Research output

Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Research output: Contribution to journalReview articleAcademicpeer-review

Associated researcher

Associated organisations

    Research areas

  • BRENTUXIMAB VEDOTIN, HEALTH, DESIGN
View graph of relations

Details

Original languageEnglish
Pages (from-to)1195-1207
Number of pages13
JournalPharmacoeconomics
Volume37
Issue number10
DOIs
Publication statusPublished - Oct 2019